Citation Impact
Citing Papers
Diabetes and Cardiovascular Disease
1999 Standout
High-Resolution Crystal Structure of an Engineered Human β 2 -Adrenergic G Protein–Coupled Receptor
2007 StandoutScienceNobel
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
2002 Standout
Cardiovascular and Metabolic Alterations in Mice Lacking Both β1- and β2-Adrenergic Receptors
1999 StandoutNobel
A pilot study of garlic consumption shows no significant effect on markers of oxidation or sub-fraction composition of low-density lipoprotein including lipoprotein(a) after allowance for non-compliance and the placebo effect
1999
Gene Substitution/Knockout to Delineate the Role of α2‐Adrenoceptor Subtypes in Mediating Central Effects of Catecholamines and Imidazolines
1999 StandoutNobel
Oxidative stress and normal pregnancy
2002
First United Kingdom Heart and Renal Protection (UK-HARP-I) study: Biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease
2005 StandoutNobel
Lipoprotein subclasses and coronary artery calcium in postmenopausal women from the healthy women study
2002
The metabolic syndrome
2010 Standout
A review of the receptor-binding and pharmacokinetic properties of dopamine agonists
2006
Effect of targeted deletions of β1- and β2-adrenergic-receptor subtypes on heart rate variability
2005 StandoutNobel
Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents
2017 Standout
Computational Methods in Drug Discovery
2014
Effect of garlic on cardiovascular disorders: a review
2002 Standout
Nitric oxide and oxidative stress in vascular disease
2010 Standout
Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation
2003 Standout
The metabolic syndrome
2005 Standout
Physiological consequences of β-adrenergic receptor disruption
1998
Premature cardiovascular disease in chronic renal failure
2000
Microfluidic organs-on-chips
2014 Standout
Integration ofin silicoandin vitroplatforms for pharmacokinetic–pharmacodynamic modeling
2010
Differential cardioprotective/cardiotoxic effects mediated by β-adrenergic receptor subtypes
2005 StandoutNobel
Prevalence of the Metabolic Syndrome Among US Adults
2002 Standout
LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA)
2006
Low-Density Lipoprotein Size and Cardiovascular Disease: A Reappraisal
2003
Seven-transmembrane-spanning receptors and heart function
2002 StandoutNatureNobel
Skeletal muscle hypertrophy and anti‐atrophy effects of clenbuterol are mediated by the β2‐adrenergic receptor
2002 StandoutNobel
ERK Plays a Regulatory Role in Induction of LTP by Theta Frequency Stimulation and Its Modulation by β-Adrenergic Receptors
1999 StandoutNobel
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis
2006 Standout
Atorvastatin in Patients with Type 2 Diabetes Mellitus Undergoing Hemodialysis
2005 Standout
The determination and interpretation of the therapeutic index in drug development
2012
Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy
2010 Standout
Association Between Carotid Intima-Media Thickness and Low-Density Lipoprotein Size and Susceptibility of Low-Density Lipoprotein to Oxidation in Asymptomatic Members of Familial Combined Hyperlipidemia Families
2002
Relation of Lipoprotein Subclasses as Measured by Proton Nuclear Magnetic Resonance Spectroscopy to Coronary Artery Disease
1998
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Physiological Basis of Transcranial Direct Current Stimulation
2011 Standout
Molecular Docking and Structure-Based Drug Design Strategies
2015 Standout
Functional Consequences of Altering Myocardial Adrenergic Receptor Signaling
2000 StandoutNobel
Abnormal cardiac function associated with sympathetic nervous system hyperactivity in mice
2002 StandoutNobel
Molecular Docking: Shifting Paradigms in Drug Discovery
2019 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Small, Dense Low-Density Lipoprotein Particles as a Predictor of the Risk of Ischemic Heart Disease in Men
1997
Chimeric Antigen Receptor Therapy
2018 Standout
The Metabolic Syndrome, LDL Particle Size, and Atherosclerosis
2000
Alterations in dynamic heart rate control in the β1-adrenergic receptor knockout mouse
1998 StandoutNobel
The Metabolic Syndrome
2008 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Cholesterol Synthesis Inhibition Elicits an Integrated Molecular Response in Human Livers Including Decreased ACAT2
2008 StandoutNobel
Interrater Reliability and Effect of State on Blood Pressure Measurements in Infants 1 to 3 Years of Age
2008
INSIGHTS FROM IN VIVO MODIFICATION OF ADRENERGIC RECEPTOR GENE EXPRESSION
1998 StandoutNobel
Hormone therapy, lipoprotein subclasses, and coronary calcification: the Healthy Women Study.
2005
Intensive Lipid Lowering by Statin Therapy Does Not Improve Vasoreactivity in Patients With Type 2 Diabetes
2002
Works of Iris Rajman being referenced
Adverse change in low-density lipoprotein subfractions profile with oestrogen-only hormone replacement therapy
1996
Inhibitory effects of low-density lipoproteins from men with type II diabetes on endothelium-dependent relaxation
2000
A Risk-Benefit Assessment of Celiprolol in the Treatment of Cardiovascular Disease
1994
Investigation of low density lipoprotein subfractions as a coronary risk factor in normotriglyceridaemic men
1996
Pergolide
2005
Low-density lipoprotein subfraction profiles in chronic renal failure
1998
Particle size: the key to the atherogenic lipoprotein?
1994
PK/PD modelling and simulations: utility in drug development
2008
LDL particle size: an important drug target?
1999
Evaluation of Methods for Improving Precision of Blood Pressure Measurements in Phase I Clinical Trials
2004